Atea Pharmaceuticals, Inc. (AVIR)
NASDAQ: AVIR · IEX Real-Time Price · USD
3.560
-0.010 (-0.28%)
Jul 22, 2024, 10:10 AM EDT - Market open
Atea Pharmaceuticals Employees
Atea Pharmaceuticals had 75 employees as of December 31, 2023. The number of employees increased by 5 or 7.14% compared to the previous year.
Employees
75
Change (1Y)
5
Growth (1Y)
7.14%
Revenue / Employee
n/a
Profits / Employee
-$2,182,107
Market Cap
299.08M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 75 | 5 | 7.14% |
Dec 31, 2022 | 70 | 11 | 18.64% |
Dec 31, 2021 | 59 | 20 | 51.28% |
Dec 31, 2020 | 39 | - | - |
Related Stocks
Company Name | Employees |
---|---|
Adaptimmune Therapeutics | 449 |
SOPHiA GENETICS | 430 |
Poseida Therapeutics | 330 |
Sutro Biopharma | 302 |
Pulmonx | 279 |
Enanta Pharmaceuticals | 145 |
Jasper Therapeutics | 45 |
Opthea | 24 |
AVIR News
- 7 weeks ago - Atea Pharmaceuticals to Present at the Jefferies Healthcare Conference - GlobeNewsWire
- 2 months ago - Atea Pharmaceuticals Presents New Data Showcasing Potential Best-in-Class Combination Profile of Bemnifosbuvir and Ruzasvir for Treatment of Hepatitis C Virus at EASL Congress 2024 - GlobeNewsWire
- 3 months ago - Atea Announces Presentation of Data Highlighting Favorable Safety Profile of Bemnifosbuvir at ESCMID Global 2024 - GlobeNewsWire
- 4 months ago - Atea Pharmaceuticals Completes Patient Enrollment in Global Phase 3 SUNRISE-3 Trial Evaluating Oral Antiviral Bemnifosbuvir for COVID-19 in High-Risk Patients - GlobeNewsWire
- 5 months ago - Atea Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update - GlobeNewsWire
- 5 months ago - Atea Pharmaceuticals to Host Fourth Quarter and Full Year 2023 Financial Results Conference Call on February 28, 2024 - GlobeNewsWire
- 6 months ago - Atea Pharmaceuticals Announces Positive Initial Data from Phase 2 Study for Hepatitis C Virus (HCV) and Significant Enrollment Milestone for Phase 3 SUNRISE-3 Trial for COVID-19 - GlobeNewsWire
- 7 months ago - Atea Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire